Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Single-center, Open-label, Randomized, Two-stage, Two-way Crossover Study to Evaluate the Differences in Pharmadynamics, Pharmacokinetics, and Safety Between Ciprofol and Propofol at Different Doses in Healthy Subjects

Next Previous
X
Search
Trial Profile

A Single-center, Open-label, Randomized, Two-stage, Two-way Crossover Study to Evaluate the Differences in Pharmadynamics, Pharmacokinetics, and Safety Between Ciprofol and Propofol at Different Doses in Healthy Subjects

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 24 Nov 2020

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cipepofol (Primary) ; Propofol
  • Indications Anaesthesia
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Haisco Pharmaceutical Group; Sichuan Haisco Pharmaceutical

    • Most Recent Events

    • 28 Oct 2020 Status changed from not yet recruiting to completed.
    • 05 Oct 2020 Results presented at the ANESTHESIOLOGY 2020 Annual Meeting of the American Society of Anesthesiologists
    • 17 Jun 2020 Planned initiation date changed from 25 May 2020 to 26 Jul 2020.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top